Schizophrenia is a severe neuropsychiatric disorder characterized by hallucinations, false beliefs about oneself or the world (i.e., delusions), and other disruptions in thought, emotion and perception. Recent genetic studies show that many risk variants for […]
A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more […]
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) and South London and Maudsley NHS Foundation Trust has shown striking inequalities between ethnic groups in the rate of involuntary admissions to mental health […]
In season three of the hit television series “The White Lotus,” the character Victoria Ratliff takes the prescription anti-anxiety medication lorazepam to help with her social anxiety and inability to sleep. Her casual usage of […]
Harvard Medical School researchers report that higher day-to-day “trigger surprisal” scores were associated with migraine attacks over the next 12 and 24 hours. In this cohort, higher surprisal scores aligned with greater odds of a […]
People can think, behave and function very differently. These observed differences are known to be the result of complex interactions between genetics, neurobiological processes and life experiences.This article was originally published on MedicalXpress.com
Providing parenting help through schools led to a significant reduction in anxiety and behavioral problems among children, according to the results of a national study.This article was originally published on MedicalXpress.com
The success of the United Nations’ global sustainability targets is often measured through economic growth—but what about how people feel and live?This article was originally published on MedicalXpress.com
The stereotypical image of psychotherapy shows a patient lying on a couch, exploring their deepest traumas. This leads to awareness of unconscious habits, thoughts, and drives and has long been a cornerstone of psychotherapy. However, […]
The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca